5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)
Oncology Reports · 07.08.2023 · 50 (4)
DOI: 10.3892/or.2023.8612 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 07.08.2023. Verfasst von Shiekhah M Alzahrani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia. Hauptthemen laut MEDLINE: Fluorouracil, Colorectal Neoplasms. Die Arbeit wurde bisher 151-mal zitiert (Crossref) und nennt 125 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry Department, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
- Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Zitieren
APA
Alzahrani, S. M., Al Doghaither, H. A., Al-Ghafari, A. B., & Pushparaj, P. N. (2023). 5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review). Oncology Reports, 50(4). https://doi.org/10.3892/or.2023.8612
Vancouver
Alzahrani SM, Al Doghaither HA, Al-Ghafari AB, Pushparaj PN. 5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review). Oncology Reports. 2023;50(4). doi:10.3892/or.2023.8612
BibTeX
@article{Alzahrani2023,
author = {Alzahrani, Shiekhah M and Al Doghaither, Huda A and Al-Ghafari, Ayat B and Pushparaj, Peter N},
title = {5‑Fluorouracil and capecitabine therapies for the treatment of colorectal cancer (Review)},
journal = {Oncology Reports},
year = {2023},
volume = {50},
number = {4},
doi = {10.3892/or.2023.8612}
}
EUVIMED